This review aims to investigate the effectiveness of GLP-1 analogues in patients with type 2 diabetes mellitus who are not achieving satisfactory glycaemic control with one or more oral glucose lowering drugs. This evidence concerns the gene GCG and type 2 diabetes mellitus.